dengu
caus
four
serotyp
dengu
viru
denv
repres
expand
global
health
challeng
potenti
serotypecrossreact
antibodi
exacerb
diseas
secondari
infect
heterolog
denv
serotyp
driven
effort
studi
human
denvspecif
antibodi
denvspecif
antibodi
gener
human
serotypecrossreact
weakli
neutral
direct
immatur
premembran
prm
envelop
e
nonstructur
protein
broaden
character
human
denvspecif
antibodi
assess
bcell
respons
elispot
assay
isol
b
cell
peripher
blood
human
subject
previou
denv
infect
fortyeight
human
igg
monoclon
antibodi
hmab
initi
character
potenti
bind
inactiv
lysat
denvinfect
cell
subsequ
denvspecif
hmab
found
bind
solubl
recombin
e
protein
two
hmab
unabl
bind
despit
strongli
bind
denvinfect
cell
lysat
analys
show
two
hmab
bound
conformationdepend
reductionsensit
epitop
e
protein
data
shed
light
breadth
denvspecif
hmab
gener
within
singl
immun
donor
engu
virus
denv
compris
famili
four
antigenicallyrel
positivestrand
rna
virus
transmit
human
mosquito
denv
infect
asymptomat
clinic
diseas
rang
acut
febril
ill
last
classic
dengu
fever
sever
form
dengu
hemorrhag
fever
dhf
character
fever
hemorrhag
manifest
increas
vascular
permeabl
leakag
interstiti
space
primari
infect
one
serotyp
denv
induc
lifelong
immun
serotyp
strong
associ
sever
dengu
ill
dhf
heterolog
secondari
infect
high
cytokin
level
led
prevail
view
dhf
immunolog
mediat
antibodydepend
enhanc
ade
infect
wherebi
antidenv
antibodi
acquir
previou
heterolog
infect
passiv
acquir
infant
mother
thought
import
trigger
immunolog
cascad
respons
dhf
initi
studi
antibodi
respons
denv
perform
mice
major
flavivirusneutr
murin
antibodi
recogn
structur
envelop
e
protein
although
also
bind
immatur
premembran
prm
matur
membran
protein
serotypespecif
epitop
elicit
murin
antibodi
strongest
neutral
activ
protect
anim
antibodi
correl
neutral
activ
vitro
base
epitopemap
studi
mani
denv
serotypespecif
neutral
antibodi
local
domain
iii
diii
e
protein
wherea
neutral
monoclon
antibodi
mab
crossreact
flavivirus
local
primarili
domain
ii
dii
near
fusion
sequenc
recent
human
antibodi
respons
evalu
analyz
qualiti
antibodi
sera
denvimmun
individu
last
coupl
year
sever
group
gener
character
human
h
mab
stimul
memori
b
cell
obtain
denvimmun
donor
vitro
antibodi
specif
e
protein
poor
moder
potent
neutral
activ
antibodi
specif
prm
protein
poorli
neutral
highli
crossreact
isol
contrast
find
mice
antibodi
diii
minor
human
immun
sera
among
isol
hmab
bcell
elispot
assay
repres
altern
approach
analyz
human
bcell
respons
denv
recent
report
use
elispot
assay
compar
respons
homolog
heterolog
denv
serotyp
primari
secondari
denv
infect
elispot
assay
allow
accur
quantit
cell
frequenc
isol
mab
definit
serotyp
crossreact
clonal
level
difficult
goal
present
studi
expand
isol
b
cell
secret
antibodi
specif
denv
peripher
blood
individu
follow
denv
infect
defin
major
antigen
epitop
recogn
panel
antibodi
secret
memori
b
cell
singl
denvimmun
subject
character
phenotyp
b
cell
continu
secret
denvspecif
antibodi
longterm
sampl
obtain
five
denvimmun
subject
tabl
peripher
blood
mononuclear
cell
pbmc
purifi
resuspend
cellsml
rpmi
medium
gibco
carlsbad
ca
supplement
fetal
bovin
serum
fb
sigmaaldrich
st
loui
mo
dimethyl
sulfoxid
dmso
cryopreserv
use
cryopreserv
pbmc
thaw
wash
twice
cell
count
dilut
ml
rpmi
gibco
fb
gibco
uml
penicillin
streptomycin
gibco
mm
lglutamin
gibco
pbmc
stimul
lgml
invivogen
san
diego
ca
uml
recombin
human
rh
peprotech
rocki
hill
nj
cell
ad
plate
co
elispot
assay
perform
supernat
stimul
pbmc
collect
assess
antibodi
secret
isol
hmab
memori
b
cell
isol
magnet
sort
mac
kit
ms
miltenyi
biotec
bergisch
gladbach
germani
immort
epsteinbarr
viru
ebv
presenc
lgml
cpg
operon
technolog
alameda
ca
uml
lgml
holotransferrin
sigmaaldrich
previous
describ
cell
plate
cellswel
plate
maintain
biweekli
stimul
cpg
transferrin
supernat
regularli
collect
test
antibodi
secret
elispot
assay
perform
previous
describ
briefli
well
millipor
elispot
plate
millipor
billerica
coat
denv
e
protein
lgml
hawaii
biotech
aiea
hi
strain
use
gener
four
denv
protein
strain
strain
strain
strain
detect
total
igg
well
coat
antihuman
igg
lgml
mabtech
nacka
strand
sweden
plate
store
overnight
bcell
bulk
cultur
count
cell
ad
well
duplic
plate
incub
overnight
wash
biotinyl
mab
direct
human
igg
lgml
fb
mabtech
ad
plate
incub
h
room
temperatur
wash
develop
horseradish
peroxidas
hrp
conjug
streptavidin
dilut
fb
bd
pharmingen
san
diego
ca
plate
analyz
use
ctl
immunospot
reader
ctl
shaker
height
oh
e
antibodi
supernat
bcell
cultur
detect
use
enzymelink
immunosorb
assay
elisa
standard
assay
micropl
coat
overnight
ngwell
e
protein
hawaii
biotech
dilut
uninfect
control
vero
cell
lysat
infecti
immatur
denv
virion
recombin
protein
express
drosophila
sp
cell
known
bind
nativ
conformationdepend
mab
furthermor
xray
crystallographi
studi
demonstr
protein
retain
nativelik
structur
antigen
prepar
infect
vero
cell
monolay
previous
describ
briefli
vero
cell
monolay
infect
multipl
infect
moi
plaqueform
unit
pfu
cell
incub
minim
essenti
medium
mem
supplement
mm
acid
hepe
mm
glutamin
uml
penicillin
mgml
streptomycin
fb
gibco
cell
display
cytopatholog
cell
harvest
wash
fix
glutaraldehyd
pb
min
ice
wash
resuspend
rpmi
suspens
fix
cell
sonic
ice
sonic
dismembr
fisher
chemic
loughborough
uk
centrifug
g
min
supernat
collect
aliquot
frozen
viral
antigen
control
antigen
prepar
similarli
uninfect
vero
cell
monolay
immatur
denv
particl
produc
human
adenocarcinoma
lovo
cell
atcc
describ
previous
briefli
lovo
cell
infect
denv
serumfre
ham
medium
life
technolog
grand
island
ny
moi
viru
inoculum
remov
h
fresh
medium
ad
wash
cell
twice
pb
medium
contain
viru
particl
harvest
clear
cellular
debri
lowspe
centrifug
aliquot
store
transform
bcell
cultur
also
screen
antibodi
product
use
modifi
elisa
modifi
assay
plate
coat
concanavalin
cona
vector
laboratori
burlingam
ca
lgml
hepe
gibco
total
volum
llwell
h
well
wash
serumfre
denv
prepar
ad
h
undilut
supernat
contain
murin
mab
atcc
bind
e
use
posit
control
screen
process
neg
control
consist
cultur
fluid
grown
parallel
viru
plate
block
bovin
serum
albumin
bsa
min
dilut
antibodi
ad
well
h
plate
wash
pb
contain
goat
antihuman
igg
coupl
hrp
bethyl
laboratori
inc
montgomeri
tx
ad
secondari
antibodi
dilut
tmb
peroxidas
substrat
kpl
gaithersburg
md
ad
substrat
approxim
min
enzym
reaction
stop
addit
hydrochlor
acid
plate
read
nm
cell
gift
dr
vineet
kewal
ramini
nation
cancer
institut
frederick
md
infect
moi
incub
h
cell
wash
incub
co
h
fb
uninfect
infect
cell
either
permeabil
stain
directli
hmab
approxim
cell
permeabil
cytofixcytoperm
bd
bioscienc
san
jose
ca
stain
antibodi
min
wash
fac
buffer
sodium
azid
cell
stain
fluorescein
isothiocyan
fitc
conjug
antihuman
igg
sigmaaldrich
approxim
cell
analyz
sampl
data
collect
bd
facsaria
bd
bioscienc
analyz
use
flowjo
version
softwar
tree
star
inc
ashland
denvinfect
vero
cell
lysat
prepar
lyse
vero
cell
ripa
buffer
mm
nacl
mm
tri
sodium
dodecyl
sulfat
sd
igep
ice
h
supernat
analyz
sdspolyacrylamid
gel
electrophoresi
sdspage
use
denatur
gel
prestain
protein
marker
adjac
lane
separ
protein
electrotransf
use
mini
transblot
electrophoret
cell
biorad
laboratori
hercul
ca
onto
polyvinyliden
difluorid
pvdf
membran
biorad
electroblot
perform
presenc
mm
glycin
mm
tri
base
methanol
constant
current
overnight
room
temperatur
transfer
protein
onto
membran
visual
verifi
prestain
precis
plu
kaleidoscop
standard
biorad
membran
block
overnight
nonfat
milk
pb
gentl
shake
block
solut
replac
primari
antibodi
solut
dilut
block
solut
incub
overnight
gentl
shake
thereaft
blot
wash
three
time
pbst
mm
phosphat
buffer
ph
mm
nacl
min
follow
incub
antihuman
igghrpconjug
antibodi
solut
dilut
block
solut
bethyl
laboratori
min
blot
wash
describ
protein
band
visual
chemiluminesc
hrpconjug
antibodi
detect
reagent
denvil
scientif
inc
metuchen
nj
two
set
micropl
coat
overnight
dilut
inactiv
lysat
con
aimmobil
plate
block
bsa
min
incub
seriallydilut
supernat
hmab
duplic
h
plate
wash
one
set
plate
incub
urea
min
set
plate
wash
incub
antihuman
igghrp
bethyl
laboratori
h
tmb
solut
ad
enzym
reaction
stop
addit
hydrochlor
acid
absorb
valu
greater
twofold
background
consid
posit
avid
indic
calcul
ratio
optic
densiti
od
urea
od
without
urea
vero
cell
seed
plate
densiti
cell
per
well
incub
overnight
cultur
supernat
serial
dilut
mem
contain
bsa
supplement
penicillin
streptomycin
ad
antibodi
incub
h
viru
mab
mixtur
ad
vero
cell
achiev
moi
plate
incub
co
h
approxim
ml
mem
contain
fb
ad
well
plate
incub
co
h
well
wash
ml
pb
plate
incub
ml
trypsinwel
min
wash
ml
pb
contain
fb
cell
pipet
break
clump
centrifug
g
min
cell
permeabil
use
cytofixcytoperm
stain
dilut
denvspecif
util
bcell
elispot
assay
enumer
antibodysecret
cell
asc
pbmc
obtain
five
adult
either
receiv
live
attenu
dengu
vaccin
natur
expos
denv
infect
tabl
serotyp
denv
identifi
rtpcr
one
subject
donor
remain
four
subject
enrol
acut
denv
infect
viru
detect
pbmc
cultur
presenc
tolllik
receptor
tlr
agonist
activ
memori
b
cell
secret
antibodi
use
recombin
r
e
protein
identifi
denvspecif
asc
detect
denv
especif
asc
pbmc
donor
asc
donor
fig
next
use
supernat
pbmc
assess
whether
breadth
serotyp
crossreact
antibodi
denv
protein
detect
elispot
also
reflect
antibodi
secret
memori
b
cell
detect
secret
especif
antibodi
donor
one
donor
test
antibodi
donor
fig
data
demonstr
presenc
serotypecrossreact
antibodi
subject
vari
histori
denv
infect
includ
singl
exposur
viru
next
want
isol
memori
bcellderiv
hmab
donor
indepth
character
serotypespecif
neutral
potenc
memori
b
cell
immort
ebv
cpg
previous
describ
maintain
cellswel
plate
hand
bcell
line
donor
maintain
cultur
continu
secret
antibodi
long
period
cell
retain
express
consist
previou
report
ebvmedi
bcell
transform
immort
bcell
cultur
supernat
screen
igg
antibodi
bound
inactiv
lysat
cell
sinc
elispot
assay
indic
respons
strongest
subject
fig
lysatespecif
igg
antibodi
detect
well
data
shown
select
well
od
valu
time
background
analysi
well
initi
select
cell
well
continu
secret
antibodi
underw
extens
character
supernat
collect
well
everi
wk
test
elisa
defin
major
antigen
recogn
assess
serotypespecif
antibodi
supernat
lysateposit
well
use
inactiv
cell
lysat
four
serotyp
denv
found
hmab
abl
bind
one
dengu
antigen
serotypespecif
bound
antigen
fig
sinc
inactiv
cell
lysat
contain
multipl
structur
nonstructur
protein
denv
next
test
supernat
recognit
denv
protein
major
target
antidenv
antibodi
found
well
recogn
protein
supernat
recogn
protein
supernat
recogn
either
fig
antibodi
recogn
protein
serotypespecif
respons
predominantli
e
crossreact
recogn
one
serotyp
e
fig
c
rel
concentr
specif
viral
compon
cell
lysat
unknown
could
explain
qualit
differ
antibodi
recognit
denvinactiv
lysat
recombin
protein
sinc
b
cell
seed
cellswel
also
exclud
possibl
chang
rel
concentr
polyclon
ab
present
within
well
time
may
impact
result
howev
given
low
frequenc
memori
b
cell
pbmc
believ
unlik
data
indic
mab
gener
memori
b
cell
donor
recogn
e
produc
solubl
recombin
antigen
major
antibodi
serotypecrossreact
recent
sever
group
identifi
prm
protein
domin
target
antidenv
human
antibodi
character
two
mab
potenti
bind
prm
protein
sinc
recogn
elisa
fig
hmab
abl
recogn
inactiv
lysat
antigen
fig
data
shown
mab
abl
recogn
lysat
better
lysat
consist
next
test
antibodi
standard
elisa
abil
bind
infecti
denv
viru
denv
viru
produc
lovo
cell
known
enrich
immatur
viru
particl
express
prm
neither
bound
infecti
viru
immatur
viru
produc
lovo
cell
data
shown
modifi
elisa
affinityimmobil
viral
glycoprotein
use
cona
detect
substanti
bind
mab
less
bind
fig
data
suggest
mab
bound
conformationsensit
epitop
e
protein
present
protein
produc
drosophila
cell
supernat
well
next
test
reactiv
denv
nonreduc
western
blot
dengu
virion
solubil
subject
western
blot
analysi
identifi
viral
structur
protein
recogn
mab
inactiv
lysat
dengu
viru
also
use
identifi
structur
nonstructur
protein
mab
recogn
band
kda
expect
molecular
weight
e
protein
nonreduc
condit
previou
studi
mous
anti
mab
shown
mab
lost
reactiv
upon
treatment
bmercaptoethanol
reduc
condit
therefor
sensit
protein
conform
support
disulfid
bridg
bind
mab
e
abolish
viru
lysat
subject
reduc
condit
supplementari
figur
see
onlin
supplementari
materi
http
wwwliebertonlinecom
specul
mab
would
differ
avid
friberg
et
al
lysat
could
reflect
serotyp
viru
donor
infect
calcul
avid
index
present
valu
obtain
differ
concentr
mab
show
posit
elisa
result
data
indic
mab
higher
avid
index
lysat
fig
overal
avid
index
conaimmobil
infecti
denv
lower
compar
inactiv
lysat
mab
also
higher
avid
index
virion
fig
next
test
neutral
activ
mab
use
flowbas
neutral
assay
vero
cell
neutral
reach
plateau
mab
mab
incub
variou
dilut
shown
repres
dot
plot
depict
infect
presenc
dilut
mab
fig
togeth
data
indic
mab
bound
reductionsensit
epitop
e
protein
denv
mab
higher
avid
compar
poor
neutral
activ
vitro
sinc
denv
e
protein
predominantli
express
cytoplasm
transport
cell
surfac
virusinfect
cell
next
determin
whether
mab
abl
bind
nonpermeabil
andor
permeabil
virusinfect
cell
cell
infect
viru
moi
h
later
stain
permeabil
nonpermeabil
cell
mab
antibodi
bound
permeabil
nonpermeabil
virusinfect
cell
although
stain
permeabil
infect
cell
fig
g
greater
nonpermeabil
cell
fig
h
uninfect
cell
fig
cell
stain
secondari
antibodi
fig
f
lowlevel
background
stain
human
b
cell
express
number
marker
aid
distinguish
naiv
b
cell
memori
b
cell
antibodysecret
plasmablast
plasma
cell
examin
phenotyp
ebvtransform
b
cell
donor
prolifer
maintain
secret
denvspecif
antibodi
b
cell
line
secret
mab
express
fig
express
marker
associ
memori
b
cell
plasma
cell
differenti
activ
memori
b
cell
differenti
link
prolifer
induc
either
antigen
bind
trigger
tlr
find
indic
express
activ
marker
marker
associ
plasma
cell
addit
cell
line
express
high
level
intracellular
igg
littl
cellsurfac
igg
togeth
data
suggest
b
cell
donor
maintain
abil
secret
denvspecif
antibodi
igg
b
cell
friberg
et
al
assess
breadth
magnitud
antibodi
secret
human
memori
bcell
line
singl
donor
prior
exposur
denv
antibodi
bound
inactiv
lysat
denv
antibodi
bound
protein
denvspecif
hmab
identifi
serotyp
crossreact
shown
group
character
detail
two
antibodi
bind
protein
produc
drosophila
cell
bound
reductionsensit
epitop
e
protein
deriv
whole
viru
virusinfect
cell
lysat
protein
use
studi
contain
fulllength
protein
lack
membraneproxim
region
transmembran
domain
possibl
mab
target
region
also
possibl
antibodi
bind
epitop
poorli
access
surfac
matur
virion
cryptic
form
multipl
e
protein
close
proxim
find
accord
sever
recent
report
character
hmab
denvimmun
donor
studi
beltramello
et
al
dejnirattisai
et
al
indic
denv
e
protein
domain
iii
ediii
bind
antibodi
repres
fraction
antibodi
gener
immun
subject
work
done
wahala
et
al
indic
small
fraction
neutral
activ
human
denv
immun
sera
ediiispecif
assess
whether
antibodi
gener
memori
b
cell
direct
specif
domain
e
protein
mab
recogn
lysat
better
lysat
howev
ab
recogn
conaimmobil
virion
better
virion
avid
assay
indic
stronger
bind
lysat
virion
compar
find
interest
sinc
donor
report
travel
northern
thailand
ongo
outbreak
mab
character
poorli
neutral
denv
infect
vitro
know
play
role
vivo
de
alwi
et
al
character
three
mab
strongli
neutral
denv
infect
vitro
found
bound
complex
epitop
express
e
protein
assembl
viru
particl
data
add
exist
literatur
number
neutral
nonneutr
denvspecif
antibodi
bind
epitop
may
recogn
quarternari
structur
intact
virion
denv
recent
compar
denvspecif
bcell
respons
elispot
cohort
thai
children
primari
secondari
denv
infect
data
indic
weak
inconsist
correl
denvspecif
antibodi
titer
serum
frequenc
denvspecif
memori
b
cell
blood
know
result
hmab
correl
neutral
properti
polyclon
immun
serum
donor
abund
nonneutr
weakli
neutral
hmab
gener
denvspecif
memori
b
cell
suggest
small
fraction
denvspecif
antibodi
immun
sera
respons
major
vitro
neutral
howev
individu
antibodi
weakli
neutral
may
function
differ
polyclon
milieu
hand
antibodi
may
actual
serv
enhanc
viral
replic
fcrexpress
cell
shown
sever
group
humor
immun
system
mani
mechan
contribut
viral
control
antibodi
may
redirect
viru
noninfect
environ
trigger
immun
complex
lysi
antibodydepend
cellmedi
cytotox
adcc
local
cytokin
secret
studi
need
understand
properti
hmab
denvimmun
donor
relat
properti
serum
antibodi
b
cell
secret
denvspecif
antibodi
character
studi
undergon
activ
prolifer
vitro
condit
use
modifi
approach
stimul
memori
b
cell
secret
antibodi
use
previous
literatur
method
effect
hand
screen
denvspecif
antibodi
supernat
stimul
cell
mainten
b
cell
continu
secret
antibodi
longterm
difficult
altern
approach
wherebi
immunoglobulin
gene
molecularli
clone
result
stabl
antibodi
product
promis
bcell
line
consid
phenotyp
b
cell
secret
antidenv
antibodi
recogn
conformationsensit
e
epitop
igg
phenotyp
b
cell
donor
prior
multipl
follow
stain
primari
mab
cell
stain
secondari
fitcconjug
antihuman
igg
antibodi
repres
stain
uninfect
c
infect
f
cell
secondari
fitcconjug
antibodi
alon
shown
friberg
et
al
time
point
wk
mo
mo
postebv
immort
express
maintain
b
cell
process
immort
data
shown
abl
see
distinct
small
popul
cell
pbmc
donor
howev
found
low
express
bulk
b
cell
line
find
asc
express
marker
use
phenotyp
memori
b
cell
unexpect
express
initi
use
exclus
marker
memori
b
cell
recent
report
suggest
express
divers
previous
appreci
express
report
downregul
follow
ebv
transform
therefor
possibl
memori
b
cell
secret
mab
downregul
stimul
naiv
memori
human
b
cell
vitro
convert
cell
marker
use
bone
marrowresid
plasma
cell
whether
marker
denvspecif
asc
reflect
atyp
memori
b
cell
exist
vivo
whether
vitro
condit
use
stimul
human
b
cell
alter
phenotyp
unclear
character
hmab
singl
donor
studi
difficulti
obtain
sampl
immun
donor
wellcharacter
natur
histori
denv
infect
well
known
nevertheless
data
support
recent
find
literatur
antidenv
hmab
crossreact
direct
multipl
protein
studi
larger
cohort
donor
requir
draw
generaliz
conclus
repertoir
b
cell
avail
peripher
blood
denvimmun
donor
work
fund
nation
institut
health
grant
gate
strategi
identifi
cell
lymphocyt
gate
base
forwardand
sidescatt
profil
next
singlet
cell
select
b
cell
identifi
use
antibodi
direct
b
igm
igg
express
assess
surfac
top
panel
intracellularli
bottom
panel
